CFTR and cystic fibrosis: Furthermore, the presence of these alleles could induce a different response to the target drugs, such as elexacaftor/ivacaftor/tezacaftor, highlighting the importance of performing the CFTR-NGS in all CF patients for accurate diagnosis and for personalizing therapeutic strategies to improve patient outcomes [4,30].